Cure8 research brief
Cure8 research brief
If true, a commonly available dietary change—drinking alkalinised filtered water—might modestly affect inflammatory markers and specific gut bacteria in people with IBD in remission, which could be of interest to patients exploring lifestyle approaches alongside medical care.
Adult patients with IBD, clinicians interested in diet-and-lifestyle interventions, and researchers studying the microbiome or biomarkers in IBD.
The trial enrolled about 46 participants with IBD in remission and randomized them to consume either alkalinised filtered water or water from a mock device for three months.
Blood and stool samples were collected before and after the intervention to measure cytokine gene expression, circulating cytokines, antioxidant capacity, and faecal microbial composition by 16S-targeted qPCR.
Reported findings were modest: lower IL1B expression in PBMCs and lower IL-4 levels versus controls, and changes in levels of the Bacteroides fragilis group between groups. The abstract notes some cytokine changes were not statistically significant and the microbiome result differed by group in a specific bacterial group rather than broad diversity measures.
This brief summarizes the article abstract and does not represent a full review of the complete study methods or results.
The source content is an abstract-level report of a small randomized intervention (n≈46 completers). Results appear modest and some cytokine changes were not statistically significant. Larger, fully reported trials would be needed to confirm clinical relevance. This summary is grounded in the article abstract.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.